S543-0261 Screening compound: N-cyclopropyl-N-[9-(3-phenyl-1H-pyrazole-4-carbonyl)-1-oxa-9-azaspiro[5.5]undecan-4-yl]acetamide

S543-0261 Screening compound: N-cyclopropyl-N-[9-(3-phenyl-1H-pyrazole-4-carbonyl)-1-oxa-9-azaspiro[5.5]undecan-4-yl]acetamide
S543-0261 Screening compound: N-cyclopropyl-N-[9-(3-phenyl-1H-pyrazole-4-carbonyl)-1-oxa-9-azaspiro[5.5]undecan-4-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S543-0261
N-cyclopropyl-N-[9-(3-phenyl-1H-pyrazole-4-carbonyl)-1-oxa-9-azaspiro[5.5]undecan-4-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S543-0261

Molecular Formula

C24H30N4O3 (C24 H30 N4 O3)

Compound Name

N-cyclopropyl-N-[9-(3-phenyl-1H-pyrazole-4-carbonyl)-1-oxa-9-azaspiro[5.5]undecan-4-yl]acetamide

IUPAC name

N-cyclopropyl-N-[9-(3-phenyl-1H-pyrazole-4-carbonyl)-1-oxa-9-azaspiro[5.5]undecan-4-yl]acetamide

SMILES

CC(N(C1CC1)C1CC(CC2)(CCN2C(c2c[nH]nc2-c2ccccc2)=O)OCC1)=O

InChI

InChI=1S/C24H30N4O3/c1-17(29)28(19-7-8-19)20-9-14-31-24(15-20)10-12-27(13-11-24)23(30)21-16-25-26-22(21)18-5-3-2-4-6-18/h2-6,16,19-20H,7-15H2,1H3,(H,25,26)/t20-/m1/s1

InChI Key

GSEYWIAOUIUTAK-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD29009839

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.53

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.153

Distribution Coefficient, logD

2.153

Water Solubility, LogSw

-2.88

Polar Surface Area

63.094

Acid Dissociation Constant (pKa)

11.78

Base Dissociation Constant (pKb)

0.76

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

54.20

S543-0261 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with S543-0261 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S543-0261?
Check Price and Availability of S543-0261, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S543-0261 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S543-0261
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S543-0261
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S543-0261 available by request